{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:40Z","timestamp":1793413480413,"version":"4.5.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>A birth acellular pertussis vaccine may be a valuable alternative for immunity against infant pertussis when a pregnancy pertussis vaccine has not been administered. We assessed whether a birth dose may impair immunoglobulin G (IgG) responses to childhood pertussis boosters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Children from our previous randomized controlled trial who received a monovalent 3-component aP and hepatitis B vaccine at birth (aP group) or hepatitis B only (control group) followed by Infanrix hexa at 2, 4 and 6 months of age were randomized to receive either high or low-dose diphtheria-tetanus acellular pertussis combination vaccine (DTPa\u2014Infanrix\/dTpa\u2014Boostrix) at 18 months and 4 years of age. Serum DTPa-specific IgG was measured pre- and postboost at 18 months and 4 years to determine immunogenicity and potential hyporesponsiveness across vaccination schedules.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Children who received a neonatal aP dose had improved pertussis toxin-IgG persistence and enhanced postvaccination pertactin and filamentous hemagglutinin-IgG responses at 18 months. Hyporesponsiveness was not detected across the study period, and all schedules showed good immunogenicity to subsequent boosters. The high-dose DTPa vaccine consistently induced higher antibody titers than the low-dose dTpa vaccine. Either booster dose was able to bridge immunity between 6 months and 4 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>A birth dose of acellular pertussis vaccine does not impair antibody responses to booster doses of pertussis vaccines and may be an alternative for protection against early infant pertussis when pertussis booster has not been administered during pregnancy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004764","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T19:01:47Z","timestamp":1741633307000},"page":"476-483","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood Doses"],"prefix":"10.1097","volume":"44","author":[{"given":"Sonia M.","family":"McAlister","sequence":"first","affiliation":[{"name":"Wesfarmers Centre of Vaccines & Infectious Disease, Telethon Kids Institute, Perth, Western Australia, Australia"},{"name":"School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita H.J.","family":"van den Biggelaar","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines & Infectious Disease, Telethon Kids Institute, Perth, Western Australia, Australia"},{"name":"School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew N.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines & Infectious Disease, Telethon Kids Institute, Perth, Western Australia, Australia"},{"name":"Centre for Child Health Research, The University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Thornton","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines & Infectious Disease, Telethon Kids Institute, Perth, Western Australia, Australia"},{"name":"Centre for Child Health Research, The University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines & Infectious Disease, Telethon Kids Institute, Perth, Western Australia, Australia"},{"name":"School of Medicine"},{"name":"Western Australia Department of Health, Perth Children\u2019s Hospital, Child and Adolescent Health Service, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Marshall","sequence":"additional","affiliation":[{"name":"The Women\u2019s and Children\u2019s Health Network and the Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Nolan","sequence":"additional","affiliation":[{"name":"Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Murdoch Children\u2019s Research Institute, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McIntyre","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia"},{"name":"The Children\u2019s Hospital at Westmead, Westmead, New South Wales, Australia"},{"name":"The University of Sydney, Sydney, New South Wales, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Wood","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia"},{"name":"The Children\u2019s Hospital at Westmead, Westmead, New South Wales, Australia"},{"name":"The University of Sydney, Sydney, New South Wales, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"R2-20250514","first-page":"1","article-title":"Pertussis deaths in New Zealand without community transmission\u2014an infant immunity gap?","volume":"37","author":"McIntyre","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"R3-20250514","first-page":"433","article-title":"Pertussis vaccines: WHO position paper\u2014September 2015 [Article in English, French].","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"R4-20250514","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12889-022-12830-9","article-title":"Impact of the COVID-19 pandemic on Bordetella pertussis infections in England.","volume":"22","author":"Tessier","year":"2022","journal-title":"BMC Public Health"},{"key":"R5-20250514","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/infdis\/jiu090","article-title":"Maternal and neonatal vaccination protects newborn baboons from pertussis infection.","volume":"210","author":"Warfel","year":"2014","journal-title":"J Infect Dis"},{"key":"R6-20250514","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/INF.0b013e3181bc98d5","article-title":"Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age.","volume":"29","author":"Wood","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20250514","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jpeds.2007.09.034","article-title":"Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants.","volume":"152","author":"Knuf","year":"2008","journal-title":"J Pediatr"},{"key":"R8-20250514","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jpeds.2009.12.019","article-title":"Booster vaccination after neonatal priming with acellular pertussis vaccine.","volume":"156","author":"Knuf","year":"2010","journal-title":"J Pediatr"},{"key":"R9-20250514","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpeds.2008.03.011","article-title":"Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine.","volume":"153","author":"Halasa","year":"2008","journal-title":"J Pediatr"},{"key":"R10-20250514","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jamapediatrics.2018.2349","article-title":"Immunogenicity and safety of monovalent acellular pertussis vaccine at birth: a randomized clinical trial.","volume":"172","author":"Wood","year":"2018","journal-title":"JAMA Pediatrics"},{"key":"R11-20250514","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eclinm.2019.06.010","article-title":"The effect of maternal immunisation during pregnancy on infant vaccine responses.","volume":"13","author":"Zimmermann","year":"2019","journal-title":"EClinicalMedicine"},{"key":"R12-20250514","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/cid\/civ695","article-title":"Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.","volume":"61","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R14-20250514","doi-asserted-by":"crossref","first-page":"101360","DOI":"10.1016\/j.mex.2021.101360","article-title":"Optimising a 6-plex tetanus-diphtheria-pertussis fluorescent bead-based immunoassay.","volume":"8","author":"McAlister","year":"2021","journal-title":"MethodsX"},{"key":"R15-20250514","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/INF.0000000000000246","article-title":"Antibody and cell-mediated immunity to pertussis 4 years after monovalent acellular pertussis vaccine at birth.","volume":"33","author":"Wood","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R16-20250514","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coviro.2015.04.002","article-title":"Strategies to guide the antibody affinity maturation process.","volume":"11","author":"Doria-Rose","year":"2015","journal-title":"Curr Opin Virol"},{"key":"R17-20250514","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.immuni.2017.11.023","article-title":"Precursor frequency and affinity determine b cell competitive fitness in germinal centers, tested with germline-targeting HIV vaccine immunogens.","volume":"48","author":"Abbott","year":"2018","journal-title":"Immunity"},{"key":"R18-20250514","doi-asserted-by":"crossref","first-page":"eabi6950","DOI":"10.1126\/sciimmunol.abi6950","article-title":"Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals after mRNA vaccination.","volume":"6","author":"Goel","year":"2021","journal-title":"Sci Immunol"},{"key":"R19-20250514","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3389\/fimmu.2020.01282","article-title":"Global perspectives on immunization during pregnancy and priorities for future research and development: an International Consensus Statement.","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front Immunol"},{"key":"R20-20250514","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/infdis\/jiab505","article-title":"Safety and immunogenicity of a respiratory syncytial virus prefusion F vaccine when coadministered with a tetanus, diphtheria, and acellular pertussis vaccine.","volume":"225","author":"Peterson","year":"2022","journal-title":"J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T21:13:55Z","timestamp":1747257235000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004764","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]}}}